Low-Dose Acyclovir and Acute Renal Failure

  1. A. GIUSTINA, M.D.;
  2. G. ROMANELLI, M.D.;
  3. A. CIMINO, M.D.; and
  4. G. BRUNORI, M.D.
  1. Universitá degli Studi di Brescia,
    Spedali Civili; 25100 Brescia
    , Italy

    Excerpt

    To the editor: We report the case of a patient with severe acute renal failure associated with the administration of low-dose intravenous acyclovir.

    A 31-year-old man was hospitalized in July 1987 with swelling of the face, hands, and legs, nausea, abdominal cramps, scanty urine output, and acute hypertension. The patient had stage IV-B Hodgkin disease, diagnosed in June 1984. He was free from the disease and discontinued all treatment in July 1986, after remission was induced with four cycles of mustargen, vincristine, procarbazine, and prednisone (MOPP), followed by six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD). The patient also

    This 100-word excerpt has been provided in the absence of an abstract.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement